Cargando…

P460 The Aspergillus Lateral Flow Assay for the diagnosis of invasive Aspergillosis

POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Invasive Aspergillosis (IA) is a life-threatening opportunistic mycosis that occurs in some people with a compromised immune system. The detection of Aspergillus galactomannan (GM) rapidly gained widespread acceptance as part of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chonglong, Peng, Jie, Zhang, Yuan, Wang, Ying, Wang, He, Su, Yan, Zhou, Zeqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509959/ http://dx.doi.org/10.1093/mmy/myac072.P460

Ejemplares similares

P459 The Aspergillus lateral flow assay for the diagnosis of chronic pulmonary aspergillosis
por: Peng, Jie, et al.
Publicado: (2022)

The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

S4.2d Efficacy of LD Bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis
por: Ray, Animesh, et al.
Publicado: (2022)

P412 QuicGM Aspergillus Galactomannan Ag lateral flow assay as a practical aid to diagnose invasive Aspergillosis in high-risk hematology patients
por: Aerts, Robina, et al.
Publicado: (2022)

P447 Galactomannan lateral flow assay for the diagnosis of invasive Aspergillosis among clinically suspected patients in tertiary care center, Jodhpur, Rajasthan
por: Priya, Hari, et al.
Publicado: (2022)

257. Aspergillus Galactomannan Lateral Flow Assay for Rapid Diagnosis of Invasive Aspergillosis in Bronchoalveolar Lavage
por: Hoenigl, Martin, et al.
Publicado: (2019)

P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis
por: Hedayati, Mohammad, et al.
Publicado: (2022)

P436 A study to compare detection of Aspergillus galactomannan in patients with clinically suspected invasive Aspergillosis using the Lateral Flow Assay (LFA) in comparison with Enzyme Linked Immunosorbent Assay (ELISA) and identification of new risk factors as per BM-AspICU criteria
por: Padaki, Priyadarshini, et al.
Publicado: (2022)

Performance of Aspergillus Galactomannan Lateral Flow Assay on Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis
por: Linder, Kathleen A., et al.
Publicado: (2020)

P172 First report of Aspergillus tamarii producing influenza associated invasive pulmonary Aspergillosis
por: Sahu, Monalisa, et al.
Publicado: (2022)

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
por: Heldt, Sven, et al.
Publicado: (2017)

P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022)

P453 Aspergillus and aspergillosis in patients in an intensive care unit with mechanical ventilation
por: Trápaga, Mariana, et al.
Publicado: (2022)

P469 Feline aspergillosis caused by Aspergillus candidus: A case report
por: Fernandez, Norma B., et al.
Publicado: (2022)

P428 Evaluation of Galactomannan enzyme assay in non-hematological non-neutropenic ICU admitted patients for diagnosis of Invasive Pulmonary Aspergillosis as per EORTC criteria 2019
por: Kashyap, Sanchi, et al.
Publicado: (2022)

Evaluation of the LDBio Aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis
por: Hunter, Elizabeth Stucky, et al.
Publicado: (2020)

P390 A lateral flow assay for the immunodiagnosis of human cat-transmitted Sporotrichosis
por: Cognialli, Regielly, et al.
Publicado: (2022)

Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis
por: Ray, Animesh, et al.
Publicado: (2022)

S10.4b Pathophysiology, diagnosis, and management of chronic pulmonary Aspergillosis
por: Izumikawa, Koichi
Publicado: (2022)

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

Diagnostic Laboratory Features and Performance of an Aspergillus IgG Lateral Flow Assay in a Chronic Pulmonary Aspergillosis Cohort
por: Zhu, Rong-Sheng, et al.
Publicado: (2023)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

P059 The overexpression of efflux pump gene cdr1B resulting in voriconazole- and isavuconazole- resistance in Aspergillus fumigatus recovered from a patient with chronic pulmonary aspergillosis in China
por: Liang, Tianyu, et al.
Publicado: (2022)

P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report
por: Ahmadi, Bahram, et al.
Publicado: (2022)

Evaluation of MycAssay™ Aspergillus for Diagnosis of Invasive Pulmonary Aspergillosis in Patients without Hematological Cancer
por: Guinea, Jesús, et al.
Publicado: (2013)

P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
por: Huygens, Sammy, et al.
Publicado: (2022)

P408 Evaluation of fungal serum biomarkers in the diagnosis and for monitoring patients with post tuberculosis chronic pulmonary aspergillosis
por: Singh, Shreya, et al.
Publicado: (2022)

P144 The uncommon meets the common: Invasive Aspergillosis and tuberculosis co-infection in non-neutropenic patients— arare association
por: R, Akshatha, et al.
Publicado: (2022)

P488 Successful treatment of breakthrough invasive aspergillosis in an immunocompetent individual based on therapeutic drug monitoring: A case report
por: Yin, Xin, et al.
Publicado: (2022)

P419 Galactomannan enzyme immunoassay in invasive pulmonary aspergillosis: a cross sectional study in 2021 in a New Delhi
por: Das, Sutapa
Publicado: (2022)

P465 Aspergillosis in free-ranging Magellanic penguins
por: Trápaga, Mariana, et al.
Publicado: (2022)

P392 Comparative evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal infections
por: Singh, Shreya, et al.
Publicado: (2022)

P263 Invasive Pulmonary Aspergillosis (IPA) Among Non-Intubated COVID-19 Patients—a New Age Fungal Storm
por: Raghu, Raghapriya, et al.
Publicado: (2022)

Translating research flow cytometry assays for characterization of cellular therapeutics
por: Campbell, John DM
Publicado: (2015)

P158 Epidemiology of aspergillosis in Kuwait: a nationwide study
por: Alobaid, Khaled, et al.
Publicado: (2022)

P287 A case of cerebral aspergillosis in Sri Lanka
por: Welagedara, P.G.R.I.S., et al.
Publicado: (2022)

Evaluation of LDBio Aspergillus ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis
por: Stucky Hunter, Elizabeth, et al.
Publicado: (2019)

Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study
por: Hoenigl, Martin, et al.
Publicado: (2021)

A New and Highly Sensitive Serum Mannoprotein Lateral Flow Assay for Point-of-Care Diagnosis of Invasive Aspergillosis (Tripathy Method)
por: Chaturvedi, Chandra P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_063pes44sbjp1qermk1joun05a